Chronic Obstructive Pulmonary Disease

Showing NaN - NaN of 44

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COPD Trial in Worldwide (Benralizumab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Benralizumab
  • Placebo
  • Montgomery, Alabama
  • +400 more
Jan 11, 2023

COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Itepekimab SAR440340
  • Placebo
  • Palm Springs, California
  • +231 more
Dec 19, 2022

COPD Trial in Worldwide (Ensifentrine, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Alabaster, Alabama
  • +140 more
Nov 30, 2022

Observational Study of Obstructive Lung Disease (NOVELTY)

Active, not recruiting
  • Asthma
  • +2 more
  • Blood draw
  • +3 more
  • Loma Linda, California
  • +302 more
Nov 22, 2022

COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Dupilumab SAR231893
  • +4 more
  • Cullman, Alabama
  • +334 more
Jun 14, 2022

COPD Trial in United States (Revefenacin, Tiotropium, Revefenacin Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Jasper, Alabama
  • +38 more
May 4, 2022

COPD Trial in United States (Albuterol sulfate (ABS))

Completed
  • Chronic Obstructive Pulmonary Disease
  • Albuterol sulfate (ABS)
  • Andalusia, Alabama
  • +39 more
Nov 5, 2021

COPD, Alpha1-antitrypsin Deficiency Trial in Australia, Canada, United States (ARALAST NP 60 mg/kg, ARALAST NP 120 mg/kg,

Terminated
  • Chronic Obstructive Pulmonary Disease
  • Alpha1-antitrypsin Deficiency
  • ARALAST NP 60 mg/kg
  • +4 more
  • Peoria, Arizona
  • +16 more
Apr 17, 2021

COPD, COPD, Moderate to Very Severe COPD Trial in Canada, United States (Aclidinium Bromide, Placebo)

Completed
  • COPD
  • +2 more
  • Aclidinium Bromide
  • Placebo
  • Birmingham, Alabama
  • +467 more
Nov 8, 2018

COPD Trial in United States (QVA149, Umeclidinium/vilanterol, Placebo (umeclidinium/vilanterol ))

Completed
  • Chronic Obstructive Pulmonary Disease
  • Anaheim, California
  • +52 more
Mar 2, 2018

COPD Trial in United States (MP-376, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Haleyville, Alabama
  • +38 more
Jan 17, 2018

COPD Trial in United States (Aclidinium Bromide/Formoterol Fumarate, Formoterol Fumarate)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium Bromide/Formoterol Fumarate
  • Formoterol Fumarate
  • Birmingham, Alabama
  • +136 more
Apr 3, 2017

COPD Trial in United States (Supplemental oxygen therapy)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Supplemental oxygen therapy
  • Birmingham, Alabama
  • +38 more
Apr 3, 2017

COPD Trial in Worldwide (Aclidinium bromide/formoterol Fixed-Dose Combination (FDC), Aclidinium bromide, Formoterol Fumarate)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
  • +3 more
  • Anniston, Alabama
  • +207 more
Mar 9, 2017

COPD Trial in Canada, United States (Aclidinium Bromide 200 µg, Aclidinium Bromide 400 µg)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium Bromide 200 µg
  • Aclidinium Bromide 400 µg
  • Birmingham, Alabama
  • +112 more
Mar 9, 2017

COPD Trial in United States (tetomilast, )

Terminated
  • Chronic Obstructive Pulmonary Disease
  • Birmingham, Alabama
  • +14 more
Mar 3, 2017

COPD Trial in Australia, New Zealand, United States (GFF MDI, GP MDI, FF MDI)

Completed
  • Chronic Obstructive Pulmonary Disease
  • GFF MDI
  • +4 more
  • Andalusia, Alabama
  • +139 more
Feb 7, 2017

COPD Trial in Worldwide (Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium Bromide/Formoterol Fumarate
  • +3 more
  • Anniston, Alabama
  • +221 more
Feb 2, 2017

COPD Trial in United States (Aclidinium 400 µg / Formoterol 12 µg, Aclidinium 400 µg / Formoterol 6 µg, Aclidinium 400 µg)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium 400 μg / Formoterol 12 μg
  • +4 more
  • Glendale, Arizona
  • +19 more
Jan 16, 2017

COPD Trial in Australia, New Zealand, United States (PT005 MDI, PT001 MDI, PT003 MDI)

Completed
  • Chronic Obstructive Pulmonary Disease
  • PT005 MDI
  • +3 more
  • Glendale, Arizona
  • +19 more
Dec 7, 2016

COPD Trial in Canada, United States (Aclidinium bromide)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide
  • Birmingham, Alabama
  • +82 more
Nov 16, 2016

COPD Trial in Canada, United States (Aclidinium bromide, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide
  • Placebo
  • Birmingham, Alabama
  • +111 more
Nov 16, 2016

COPD Trial in United States (PT003, PT001, PT005)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Glendale, Arizona
  • +18 more
May 23, 2016

Chronic Obstructive Pulmonary Disease Activity: Serotonin

Unknown status
  • Chronic Obstructive Pulmonary Disease
    • San Antonio, Texas
    • +3 more
    Dec 1, 2015

    COPD Trial in United States (NVA237, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • *See Various Dept.'s*, Arizona
    • +58 more
    Mar 9, 2015